More Articles


Getting ready for primetime in cell & gene therapy

Clare Jackson, (Dec 8, 2022)

As thousands of novel cell and gene therapies advance along the development pipeline, pressure mounts for scalable treatments

Building a commercial dream team for today’s pharma industry

Brian Eastwood, (Dec 7, 2022)

The transformation in the way pharma and HCPs interact is leading pharma companies to reorganize and rethink the makeup and approach of its commercialization teams 
Patients and Medical

Digital Health: Letting human nature drive design

Katie Delaney, (Nov 22, 2022)

End users are increasingly important partners in developing digital health solutions, to the benefit of all
Access and Evidence

RWE’s new dataset: Social media

Andrew Stone, (Nov 22, 2022)

Pharma is waking up to the potential of social media to enhance existing RWD sources and to offer altogether new insights in rare disease and beyond

Scaling CGT through automation

Andrew Stone, (Nov 22, 2022)

Delivering on the promise of cell and gene therapies requires significant process improvements to cut manufacturing time and costs
Patients and Medical

Advancing health equity for the LGBTQIA+ community

Katie Delaney, (Nov 9, 2022)

Marginalised and with a range of unmet health needs, LGBTQIA+ patients are not getting the care they need. Pharma can help.

Omnichannel: How will pharma get there?

Brian Eastwood, (Nov 8, 2022)

The journey from multichannel to omnichannel requires closer data co-ordination, an agile approach, new metrics and nimbler content management
Patients and Medical

Advocacy in Hemophilia: Building the Future by Design

Clare Jackson, (Nov 3, 2022)

Creating a visionary paradigm for the future of hemophilia and rare diseases that disrupts current thinking

Becoming agile in experience measurement 

Andrew Stone, (Sep 13, 2022)

The customer experience is pharma’s new competitive battleground – trust is its key metric, and the prizes will go to the nimble
Patients and Medical

Bringing hope in hemophilia

Andrew Stone, (Sep 9, 2022)

By collaborating, gathering compelling global data and sharing knowledge hemophilia advocates are driving fairer and broader access to diagnosis and treatment